This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Type of economic evaluation
Cost-effectiveness analysis
Study objective
The aim was to explore the variation in outcomes and costs across those hospitals participating in the Randomised Assessment of Treatment using Panel Assay of Cardiac markers (RATPAC) trial, which evaluated point-of-care assessment using the panel assay or standard care, to exclude myocardial infarction, in patients with chest pain.
Interventions
The two diagnostic processes were point-of-care assessment of creatine kinase muscle brain (MB) enzyme, myoglobin, and cardiac troponin I at baseline, and at 90 minutes; and standard care, which included a range of troponin assays and creatine kinase biomarkers, according to the guidelines at each hospital.
Location/setting
UK/hospital in-patient.
Methods

Analytical approach:
The analysis was based on data from a multicentre trial, with a three-month time horizon. The authors did not state the perspective.
Effectiveness data:
The effectiveness data were from the RATPAC trial: an unblinded randomised controlled trial of 2,243 patients in six UK hospitals. The participants were adults (aged over 25 years) with acute chest pain, possibly due to myocardial infarction, within the previous 12 hours. All patients were followed-up by case note review and self-completed postal questionnaires at one and three months. The efficacy of the two diagnostic strategies was measured by the proportion of patients who were successfully discharged. Successful discharge had to fulfil two criteria: patients had either left hospital or were awaiting transport home, with a discharge decision having been made within four hours of initial presentation; and they had suffered no major adverse event in the following three months. The proportion of patients successfully discharged was analysed through logistic regression; adjusted odds ratios were calculated, taking into account age, gender, and past history of coronary heart disease. The odds ratios, with 95% confidence intervals, were reported for each hospital.
